Our purpose is to reimagine medicine to improve and extend people’s lives. We use innovative cybernetic technology to address some of society’s most challenging healthcare issues. Through AI, we discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company.

We care deeply for patients and customers, their families, our employees, and our communities. We strive to always do the right thing, pursuing the highest standards in quality, compliance, safety, and performance. We embrace diverse backgrounds and perspectives and treat everyone equally, with dignity and respect, allowing us all to achieve our best.

Our commitment to health doesn’t stop with our medical technology. Each day, we work to deliver sustainable solutions that improve the health of our business and the health of humankind.

Amongst our products in the pipeline are

SynaptiCore is an advanced cognitive enhancement drug that uses nanobots and a neural interface. The nanobots, which are the size of a red blood cell, are filled with a neuro-regenerative compound. A microprocessor in the nanobots communicates wirelessly with a small chip that is implanted behind the user’s ear. This chip, which runs an AI program, is connected to the user’s auditory cortex, allowing the user to transmit a voice command to the nanobots.

HemoGene-X is a revolutionary gene therapy that uses a bioreactive microchip embedded in a biodegradable scaffold. The chip, which is the size of a grain of rice, is programmed to detect and correct specific genetic mutations at the cellular level. When injected into the bloodstream, the microchip’s AI-powered sensors identify cells containing the targeted mutated gene. The chip then releases a CRISPR-Cas9-based gene-editing solution, which precisely edits the problematic DNA sequence.